The 5th GPCRs-Targeted Drug Discovery Summit is a focused forum spotlighting the renaissance of GPCR-targeted therapeutics.
This event guide explores novel screening platforms, structural biology advances, biased signaling, and first-in-class GPCR programs reshaping discovery pipelines.
Key themes include:
- GPCR structure and signaling bias
- Novel screening and assay platforms
- Hit identification and lead optimization
- Translational challenges in GPCR programs
About Hanson Wade Group - 5th GPCRs-Targeted Drug Discovery Summit
Advancing Small Molecules, Peptides & Antibodies to Drug Novel GPCRs in Multiple Indications with Improved Selectivity, Safety & Efficacy
The GPCR field is experiencing a renaissance, driven by renewed investment, clinical progress, and next-generation technologies unlocking hundreds of previously untargeted receptors. With rapid advances in structural biology, computation, and screening, the race is on to validate new GPCRs, understand dynamic activation mechanisms, and develop assays that better predict therapeutic efficacy and guide smarter candidate selection.
Returning as the only industry-led meeting dedicated to GPCR drug discovery, the 5th GPCR-Targeted Drug Discovery Summit features a jam-packed agenda featuring new expert voices, and fresh insights spanning the latest targets, tools, and therapeutic strategies.
Join 80+ GPCR-focused leaders across biopharma to share insights, build collaborations, and accelerate next-generation therapeutics from discovery to clinic.
Download the Event Guide
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.